Arcadia Biosciences (RKDA)
NASDAQ:RKDA
Holding RKDA?
Track your performance easily

Arcadia Biosciences (RKDA) Financial Statements

457 Followers

Arcadia Biosciences Financial Overview

Arcadia Biosciences's market cap is currently ―. The company's EPS TTM is $-5.108; its P/E ratio is -0.92; Arcadia Biosciences is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.81. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 1.31M$ 1.60M$ 1.38M$ 1.51M$ 1.00M
Gross Profit$ 673.00K$ 495.00K$ 408.00K$ 684.00K$ -553.00K
EBIT$ -2.02M$ -3.25M$ -3.80M$ -9.38M$ -4.48M
EBITDA$ -1.99M$ -3.16M$ -3.56M$ -9.13M$ -4.20M
Net Income Common Stockholders$ 1.06M$ -2.57M$ 823.00K$ -9.38M$ -4.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.11M$ 15.70M$ 18.51M$ 23.00M$ 20.60M
Total Assets$ 17.37M$ 23.47M$ 26.80M$ 30.41M$ 28.92M
Total Debt$ 574.00K$ 1.27M$ 1.52M$ 1.77M$ 2.02M
Net Debt$ -7.53M$ -14.43M$ -16.98M$ -21.23M$ -18.58M
Total Liabilities$ 5.80M$ 8.07M$ 9.07M$ 13.72M$ 8.02M
Stockholders Equity$ 11.70M$ 15.54M$ 17.87M$ 16.82M$ 21.03M
Cash Flow-
Free Cash Flow$ 1.69M$ -2.88M$ -4.80M$ -3.44M$ -2.36M
Operating Cash Flow$ -2.46M$ -2.88M$ -4.80M$ -3.47M$ -2.36M
Investing Cash Flow$ 4.64M$ 5.00K$ -4.72M$ 315.00K$ 281.00K
Financing Cash Flow-$ 5.51M-$ 5.50M-
Currency in USD

Arcadia Biosciences Earnings and Revenue History

Arcadia Biosciences Debt to Assets

Arcadia Biosciences Cash Flow

Arcadia Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis